Mark Kirschbaum
Impact in
- Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Transplantation top 1%
Papers in
-
- Histone Deacetylase Inhibitors Research 27
- Protein Degradation and Inhibitors 10
- Hematology 30
- Acute Myeloid Leukemia Research 23
- Hematopoietic Stem Cell Transplantation 9
- Chronic Myeloid Leukemia Treatments 6
- Co-authors
- Simcha Samuel (3 shared papers)Shimon Slavin (3 shared papers)Reuven Or (3 shared papers)Avraham Amar (3 shared papers)Arnon Nagler (3 shared papers)Gàbor Varadi (3 shared papers)Aliza Ackerstein (2 shared papers)Ofira Ben‐Tal (2 shared papers)
- Journals
- Blood (34 papers)Journal of Clinical Oncology (7 papers)Cancer Research (4 papers)Bone Marrow Transplantation (2 papers)Journal of Cellular Biochemistry (2 papers)
- Partner nations
- United StatesAustraliaIsrael
In The Last Decade
Mark Kirschbaum
66 papers receiving 6.2k citations
Mark Kirschbaum's Hit Papers
Peers
Comparison fields: 5 of 100
- Hematology 3.1k
- Transplantation 224
- Genetics 836
- Immunology 1.5k
- Oncology 1.8k
Countries citing papers authored by Mark Kirschbaum
This map shows the geographic impact of Mark Kirschbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kirschbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kirschbaum more than expected).
Fields of papers citing papers by Mark Kirschbaum
This network shows the impact of papers produced by Mark Kirschbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kirschbaum. The network helps show where Mark Kirschbaum may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Kirschbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases Hit paper breakdown → | 1998 | 1644 |
| 2 | Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases Hit paper breakdown → | 1998 | 1528 |
| 3 | Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma Hit paper breakdown → | 2009 | 607 |
| 4 | 1999 | 478 | |
| 5 | 2011 | 379 | |
| 6 | 2012 | 214 | |
| 7 | 2011 | 171 | |
| 8 | 2008 | 120 | |
| 9 | 2014 | 105 | |
| 10 | 2006 | 91 | |
| 11 | 2011 | 91 | |
| 12 | 2008 | 80 | |
| 13 | 2008 | 79 | |
| 14 | 2015 | 63 | |
| 15 | 2011 | 60 | |
| 16 | 2013 | 60 | |
| 17 | 1998 | 57 | |
| 18 | 2013 | 56 | |
| 19 | 2019 | 37 | |
| 20 | 1999 | 37 |
About Mark Kirschbaum
Mark Kirschbaum is a scholar working on Molecular Biology, Hematology, Oncology, Pathology and Forensic Medicine and Genetics, having authored 67 papers that have together received 6.4k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (27 papers), Acute Myeloid Leukemia Research (23 papers), Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (12 papers), Protein Degradation and Inhibitors (10 papers), Hematopoietic Stem Cell Transplantation (9 papers), Acute Lymphoblastic Leukemia research (8 papers) and Chronic Myeloid Leukemia Treatments (6 papers). The work is most often cited by research in Hematology (3.1k citations), Transplantation (224 citations), Genetics (836 citations), Immunology (1.5k citations) and Oncology (1.8k citations). Mark Kirschbaum has collaborated with scholars based in United States, Australia and Israel. Frequent co-authors include Simcha Samuel, Shimon Slavin, Reuven Or, Avraham Amar, Arnon Nagler, Gàbor Varadi, Aliza Ackerstein, Ofira Ben‐Tal, E Naparstek and Gabriel Cividalli. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer Research, Bone Marrow Transplantation and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.